| ²é¿´: 327 | »Ø¸´: 3 | ||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û2´Î£¬×÷Õßmsd2phdÔö¼Ó½ð±Ò 2 ¸ö | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
msd2phdÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
|
[×ÊÔ´]
Preformulation in Solid Dosage Form Development
|
|
|
Preformulation in Solid Dosage Form Development (Drugs and the Pharmaceutical Sciences) By Moji C. Adeyeye, Harry G. Brittain Publisher: Informa Healthcare Number Of Pages: 616 Publication Date: 2008-01-07 Covering every topic of critical importance to the preformulation stages of development, this guide equips those in the pharmaceutical industry with basic and applied principles for the characterization of new drug compounds and substances-considering the identification, stability, structure, and mechanisms of drug candidates during preformulation through Phase I of clinical trials. [ Last edited by msd2phd on 2008-6-11 at 20:17 ] |
» ²ÂÄãϲ»¶
²ÄÁϵ÷¼Á
ÒѾÓÐ10È˻ظ´
Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ085600Ó¢Ò»Êý¶þ337·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
288Çóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó ²ÄÁÏÓ뻯¹¤
ÒѾÓÐ11È˻ظ´
Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶
ÒѾÓÐ9È˻ظ´
±¾¿Æ211£¬293·ÖÇëÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
085400µç×ÓÐÅÏ¢319Çóµ÷¼Á£¨½ÓÊÜ¿çרҵµ÷¼Á£©
ÒѾÓÐ5È˻ظ´
268Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
һ־Ը˫·Ç085502£¬267·Ö£¬¹ýËļ¶Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸085404£¬×Ü·Ö291£¬Ëļ¶Òѹý£¬Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
2Â¥2008-04-03 09:27:09
3Â¥2008-04-03 09:58:50
4Â¥2008-04-03 12:31:26














»Ø¸´´ËÂ¥